Skip to main content
Log in

The TRIM family as a potential target for nonalcoholic fatty liver disease

  • Letter to the Editor
  • Published:
Human Cell Aims and scope Submit manuscript

The Original Article was published on 22 November 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Zhang J, Xie H, Yao J, Jin W, Pan H, Pan Z, et al. TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination. Hum Cell. 2022. https://doi.org/10.1007/s13577-022-00820-3.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bojkowska K, Aloisio F, Cassano M, Kapopoulou A, Santoni de Sio F, Zangger N, et al. Liver-specific ablation of Krüppel-associated box-associated protein 1 in mice leads to male-predominant hepatosteatosis and development of liver adenoma. Hepatology. 2012;56(4):1279–90. https://doi.org/10.1002/hep.25767.

    Article  CAS  PubMed  Google Scholar 

  3. Cai L, Liu G, Wei Y, Zhu Y, Li J, Miao Z, et al. Whole-genome sequencing reveals sex determination and liver high-fat storage mechanisms of yellowstripe goby (Mugilogobius chulae). Commun Biol. 2021;4(1):15. https://doi.org/10.1038/s42003-020-01541-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kettunen KM, Karikoski R, Hämäläinen RH, Toivonen TT, Antonenkov VD, Kulesskaya N, et al. Trim37-deficient mice recapitulate several features of the multi-organ disorder Mulibrey nanism. Biol Open. 2016;5(5):584–95. https://doi.org/10.1242/bio.016246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hu Y, He W, Huang Y, Xiang H, Guo J, Che Y, et al. Fatty acid synthase-suppressor screening identifies sorting nexin 8 as a therapeutic target for NAFLD. Hepatology. 2021;74(5):2508–25. https://doi.org/10.1002/hep.32045.

    Article  CAS  PubMed  Google Scholar 

  6. Xu M, Tan J, Dong W, Zou B, Teng X, Zhu L, et al. The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes. Nat Commun. 2022;13(1):1052. https://doi.org/10.1038/s41467-022-28641-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Xu MX, Tan J, Ge CX, Dong W, Zhang LT, Zhu LC, et al. Tripartite motif-containing protein 31 confers protection against nonalcoholic steatohepatitis by deactivating mitogen-activated protein kinase kinase kinase 7. Hepatology. 2022. https://doi.org/10.1002/hep.32526.

    Article  PubMed  Google Scholar 

  8. Huang C, Wei X, Luo Q, Xia Y, Pan T, He J, et al. Loss of TRIM67 attenuates the progress of obesity-induced non-alcoholic fatty liver disease. Int J Mol Sci. 2022;23(13):7475. https://doi.org/10.3390/ijms23137475.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Yu Q, Xia Z, Liong EC, Tipoe GL. Chronic aerobic exercise improves insulin sensitivity and modulates Nrf2 and NF-κB/IκBα pathways in the skeletal muscle of rats fed with a high fat diet. Mol Med Rep. 2019;20(6):4963–72. https://doi.org/10.3892/mmr.2019.10787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mingkai Chen.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Chen, M. The TRIM family as a potential target for nonalcoholic fatty liver disease. Human Cell 36, 870–871 (2023). https://doi.org/10.1007/s13577-022-00838-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13577-022-00838-7

Navigation